Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin-binding protein C gene

被引:43
作者
Berul, CI
McConnell, RK
Wakimoto, H
Moskowitz, IPG
Maguire, CT
Semsarian, C
Vargas, MM
Gehrmann, J
Seidman, CE
Seidman, JG
机构
[1] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[2] Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
arrhythmia; cardiomyopathy; electrophysiology; genetics; pathology;
D O I
10.1161/hc4701.099582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Homozygous mutant mice expressing a truncated form of myosin-binding, protein C (MyBP-C-t/t) develop severe dilated cardiomyopathy, whereas the heterozygous mutation (MyBP-C1/+) causes mild hypertrophic cardiomyopathy. Adult male MyBP-C-t/t and MyBP-Ct/+ mice were evaluated for arrhythmia vulnerability with an in vivo electrophysiology study. Methods and Results-Surface ECGs were obtained for heart rate, rhythm, and conduction intervals. Atrial, atrioventricular, and ventricular conduction parameters and refractoriness were assessed in 22 MyBP-C-t/t, 10 MyBP-C-t/t, and 17 wild-type MyBP-C+/+ mice with endocardial pacing and intracardiac electrogram recording. Arrhythmia induction was attempted with standardized programmed stimulation at baseline and with isoproterenol. Heart rate variability and ambient arrhythmia activity were assessed with telemetric ECG monitors. Quantitative histological characterization was performed on serial sections of excised hearts. MyBP-C-t/t and MyBP-Ct/+ mice have normal ECG intervals and sinus node, atrial, and ventricular conduction and refractoriness. Ventricular tachycardia was reproducibly inducible in 14 of 22 MyBP-C-t/t mice (64%) during programmed stimulation, compared with 2 of 10 MyBP-C-t/t mice (20%) and 0 of 17 wild-type controls (P <0.001). Ventricular ectopy was present only in MyBP-C-t/t mice during ambulatory ECG recordings. There were no differences in heart rate variability parameters. Interstitial fibrosis correlated with genotype but did not predict arrhythmia susceptibility within the MyBP-C-t/t group. Conclusions-MyBP-C-t/t mice, despite prominent histopathology and ventricular dysfunction, exhibit normal conduction and refractoriness, yet are vulnerable to ventricular arrhythmias. Somatic influences between genetically identical mutant mice most likely account for variability in arrhythmia susceptibility. A sarcomeric protein gene mutation leads to a dilated cardiomyopathy and ventricular arrhythmia vulnerability phenotype.
引用
收藏
页码:2734 / 2739
页数:6
相关论文
共 28 条
  • [11] LOCALIZATION OF A GENE RESPONSIBLE FOR FAMILIAL DILATED CARDIOMYOPATHY TO CHROMOSOME 1Q32
    DURAND, JB
    BACHINSKI, LL
    BIELING, LC
    CZERNUSZEWICZ, GZ
    ABCHEE, AB
    YU, QT
    TAPSCOTT, T
    HILL, R
    IFEGWU, J
    MARIAN, AJ
    BRUGADA, R
    DAIGER, S
    GREGORITCH, JM
    ANDERSON, JL
    QUINONES, M
    TOWBIN, JA
    ROBERTS, R
    [J]. CIRCULATION, 1995, 92 (12) : 3387 - 3389
  • [12] CLINICAL COURSE OF IDIOPATHIC DILATED CARDIOMYOPATHY IN CHILDREN
    FRIEDMAN, RA
    MOAK, JP
    GARSON, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (01) : 152 - 156
  • [13] Cardiac electrophysiology in genetically engineered mice
    Gehrmann, J
    Berul, CI
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (03) : 354 - 368
  • [14] Electrophysiological characterization of murine myocardial ischemia and infarction
    Gehrmann, J
    Frantz, S
    Maguire, CT
    Vargas, M
    Ducharme, A
    Wakimoto, H
    Lee, RT
    Berul, CI
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2001, 96 (03) : 237 - 250
  • [15] Phenotypic screening for heart rate variability in the mouse
    Gehrmann, J
    Hammer, PE
    Maguire, CT
    Wakimoto, H
    Triedman, JK
    Berul, CI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (02): : H733 - H740
  • [16] VALUE OF PROGRAMMED ELECTRICAL-STIMULATION USING A STANDARDIZED VENTRICULAR STIMULATION PROTOCOL IN HYPERTROPHIC CARDIOMYOPATHY
    GEIBEL, A
    BRUGADA, P
    ZEHENDER, M
    STEVENSON, W
    WALDECKER, B
    WELLENS, HJJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (08) : 738 - 739
  • [17] A mouse model of familial hypertrophic cardiomyopathy
    GeisterferLowrance, AAT
    Christe, M
    Conner, DA
    Ingwall, JS
    Schoen, FJ
    Seidman, CE
    Seidman, JG
    [J]. SCIENCE, 1996, 272 (5262) : 731 - 734
  • [18] Gruver EJ, 1999, AM J CARDIOL, V83, p13H
  • [19] PROGRAMMED ELECTRICAL-STIMULATION IN HYPERTROPHIC CARDIOMYOPATHY - RESULTS IN PATIENTS WITH AND WITHOUT CARDIAC-ARREST OR SYNCOPE
    KUCK, KH
    KUNZE, KP
    SCHLUTER, M
    NIENABER, CA
    COSTARD, A
    [J]. EUROPEAN HEART JOURNAL, 1988, 9 (02) : 177 - 185
  • [20] Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death
    Marian, AJ
    Roberts, R
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (01) : 88 - 99